Liftstream is an executive search recruitment company in the life sciences sector
Gurnet Point Capital Launches Boston Pharmaceuticals
Gurnet Point Capital, a Cambridge, MA-based US healthcare and life sciences investment firm, has founded Boston Pharmaceuticals, a fully integrated drug development company with a $600 million commitment. Christopher Viehbacher, the Managing Partner of Gurnet Point Capital and the former CEO of Sanofi, was appointed as Boston Pharmaceuticals’ Chairman. Robert Armstrong, the former head of external R&D at Chorus (Eli Lilly), was named CEO.
Posted in Executive Appointments
Tagged CEO, clincial development, executive appointment, Investment
Leave a comment
Wilson Therapeutics Raises $40m to advance development program
Authored by James Sheppard
Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Abingworth LLP, biotech, Board of Directors, CEO, Chairman, Dr Bali Muralidhar, Dr Genghis Lloyd Harris, Dr Hugh Reinhoff, Dr Marteen Steen, EMA, FDA, HealCap, Imago Bioscience, Investment, Jonas Hansson, Medicon Valley, Mr Jacob Gunterberg, MVM Life Science Partners LLP, orphan drug designation, Series B funding, venture capital, Wilson Therapeutics, Wilson's Disease, WTX101
Leave a comment
Covagen raises $63m for targeted antibody work
Authored by Karl Simpson
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged ANTI TNF/IL-17A, antibody, Ascent Biomedical Ventures, Avi Kometz, bispecific, COVA322, Covagen, Dr Dragan Grabulovski, Dr Julian Bertschinger, Dr Karl Naegler, Edmond de Rothschild], Elias Papatheodorou, ETH Zurich, Fynomers, Gimv, Investment, Medigene, Merck Serono, Micromet, Mitsubishi Tanabe Pharma Corporation, MP Healthcare Venture Management, Novartis Venture Fund, Prof Christoph Lengauer, Roche, Seroba Kernel Life Sciences, Sir Greg Winter, Third Rock Ventures, trispecific, Ventech, venture capital
Leave a comment
Medical Device Industry Engineering Emerging Markets Future
Authored by James Sheppard
Posted in Medical Device
Tagged Alpha X-Ray Technologies, Brazil, BRIC, china, China Bord Blood, Covidien, Essex Woodland, EU, GE Healthcare, India, Indonesia, Investment, J&J, Japan, Johnson & Johnson, Kanghui Holdings, LifeTech Scientific Corp, Medical Device, Meditronics, Medtronic, Microport, N-11, Omar Ishrak, Philips Healthcare, Ronald De Jong, Russia, Shanghai, Taiwan, us, Venezuela, venture capital
Leave a comment